Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125714451 | 12571445 | 1 | I | 20160701 | 20160715 | 20160719 | 20160719 | EXP | FR-GILEAD-2016-0223916 | GILEAD | 37.00 | YR | A | M | Y | 0.00000 | 20160719 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125714451 | 12571445 | 1 | PS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 245 MG, QD | 46550 | MG | N | 21356 | 245 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125714451 | 12571445 | 1 | Hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125714451 | 12571445 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125714451 | 12571445 | Blood creatine phosphokinase increased | |
| 125714451 | 12571445 | Blood phosphorus decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125714451 | 12571445 | 1 | 20151224 | 20160704 | 0 |